Guinea-Bissau reaffirms rejection of hepatitis B vaccine study
By the AFREEQUE newsroom, based on Ang
Guinea-Bissau’s Council of Ministers confirms its rejection of a study on hepatitis B vaccination in newborns, under the protocol for the Bandim Health project. The decision was taken at an extraordinary meeting in Bissau after rumours circulating on social media were examined, according to the official statement.
Guinea-Bissau’s Council of Ministers reaffirmed on Friday its rejection of a study on vaccinating newborns against hepatitis B, according to a statement issued after its extraordinary meeting in Bissau by ANG, the Guinea-Bissau News Agency. The study had been proposed under a protocol for the Bandim Health project, a health research programme conducted in Guinea-Bissau.
The Minister of Public Health also briefed participants on rumours circulating on social media about possible authorisation of the study. The Council of Ministers called for responsibility to be established and for the matter to be examined by the courts, according to the same statement.
The rest of this article is for subscribers.
Try AFREEQUE!
12,000+ readers already get the AFREEQUE newsletter
- Every article in full: all the news from Africa, summarised and easy to read
- A local source in 52 of the continent’s 54 countries
- 100% independent: no advertising, no shareholders
- The satisfaction of supporting an independent African news outlet that serves its readers
Discovery offer
€1
for 15 days
then €9.99/month
Try it for €1No commitment · cancel in one click
New subscribers only
🔒 Secure payment with:
Already a subscriber? Log in
Summary produced with the help of artificial intelligence tools, under AFREEQUE’s editorial responsibility.
